Nasdaq:US$13.45 (+0.81) | HKEX:HK$19.34 (-1.16) | AIM:£2.20 (+0.2)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 其他业务 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture